ADIPOQ and rheumatoid arthritis: Thus, multiple studies have demonstrated the harmful role of adiponectin, which exacerbated inflammation during RA pathogenesis; additionally, the serum and synovial fluid concentrations of adiponectin are higher in patients with RA [26,27].